Solutions Architect, Conversational AI & Prompt Engineering
Qventus- Full Time
- Junior (1 to 2 years)
Virta Health is pioneering a new standard of care for people to reclaim their lives. We are in the midst of a public health crisis: obesity rates are at an all-time high and over half of US adults have type 2 diabetes or prediabetes, and despite billions spent on new treatments, outcomes are largely worse. Virta reverses these diseases and delivers life-changing results by pairing individualized nutrition with ongoing care from a clinical support team. We have raised over $350 million from top-tier investors, and partner with the largest health plans, employers, and government organizations to help their employees and members restore their health and take back their lives.
This role is a chance to help shape the future of Virta’s AI-powered coaching experience and contribute to reversing chronic conditions like diabetes and obesity at scale. As a key member of the technical leadership team, you’ll play a central role in evolving our GPT-based chatbot into a powerful platform that supports coaches, engages members, and drives real health outcomes. It’s a rare opportunity to work at the intersection of GenAI, behavioral health, and mission-driven impact. You’ll collaborate closely with product, design, and engineering partners to solve complex problems at the intersection of GenAI and behavior change. If you're passionate about solving hard problems that actually help people, this is the role for you.
Reverses type 2 diabetes through personalized care
Virta Health focuses on reversing type 2 diabetes through a combination of personalized nutrition, continuous remote care, and behavioral science. Their treatment is designed for individuals diagnosed with type 2 diabetes, healthcare providers, and enterprise partners like employers and health plans. Unlike many competitors, Virta Health operates on a performance-based model, meaning they only receive payment if they achieve successful outcomes for their patients. This aligns their financial incentives with patient health improvements. The company's goal is to reverse type 2 diabetes in 100 million people, making their approach not just about managing diabetes but actively working towards its reversal.